Walgreens Investors Near Deal In Suit Over Opioid Epidemic

By Gina Kim · February 23, 2024, 6:01 PM EST

An Illinois federal judge agreed Friday to maintain a stay in a stockholder derivative suit accusing Walgreens and its leadership of failing to limit retail pharmacies from dispensing unreasonable amounts of...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion
Order

Case Information

Case Title

Vladimir Gusinsky Revocable Trust v. Pessina et al

Case Number

Court

Illinois Northern

Nature of Suit

160(Contract: Stockholders Suits)

Date Filed

November 03, 2023

Recent Articles By Gina

May 10, 2024
Atty Says Panoramic Fired Her For Raising Compliance Issues
May 09, 2024
Judge Clarifies Gilead Didn't Directly Infringe HIV Drug IP
April 29, 2024
UnitedHealth's Cyberattack Response Is 'Inadequate,' AGs Say
April 11, 2024
UnitedHealth Patients' Addiction Coverage Suit Revived, Again
April 10, 2024
US News Fights Uphill To Block SF's 'Best Hospitals' Probe
April 05, 2024
Nationwide Optometry To Pay $3.4M Over 2021 Data Breach
March 12, 2024
Walgreens, Kenvue Unit Sued Over Benzene In Acne Products
March 01, 2024
Gilead, Cipla Ink Deal To End HIV Drug Buyers' Antitrust Suit
February 29, 2024
9th Circ. Says Fight Over COVID-19 Misinformation Law Moot
February 16, 2024
Athira Pharma Investors Win OK Of $10M Deal On Second Try